Survival Outcomes According to Molecular Classification of Uterine Carcinosarcoma

Authors:

Michael D. Toboni, MD, MPH1, Kaitlyn Kincaid, MD1, Sharon Wu, PhD2, Tyler Mattox, PhD2, Matthew J. Oberley, MD2, Premal H. Thaker, MD3, Matthew A. Powell, MD3, Nathaniel Jones, MD4

Background

• Uterine carcinosarcoma (UCS) is an aggressive cancer with a poor prognosis.

• There are limited studies evaluating the molecular stratification of UCS or its association with survival outcomes.

• No survival comparisons exist between UCS and endometrioid endometrial cancer (EEC) according to molecular classification.

Download Publication